Tag Archives: Novartis

Novartis extends operations at U.K. plant for another year, keeping some 200 workers on board

As Novartis shifts away from the production of older, less profitable drugs, the drugmaker has placed a slew of production facilities in the cost-cutting crosshairs. But with the company facing increased demand for two unnamed products, one plant is set to keep on churning through next year. More than 200 Novartis manufacturing workers will keep their jobs for… Read More »

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism

Pharma companies including Pfizer, Novartis and AbbVie have paused advertising on Facebook for July. Their brands join others in the Stop Hate for Profit campaign, meant to pressure Facebook into taking action against hate and disinformation spread on its platform. Pfizer is the largest of the pharma companies participating and one of three overall top 25… Read More »

Not a kickback: Novartis’ Kymriah travel assistance program gets a green light from HHS

Normally, a pharma company paying a patient to take its drug looks suspicious—like a kickback—and it’s considered so under federal law. But HHS has just made a special ruling for a novel therapy. The federal health agency now allows Novartis to pay for travel, lodging, meals and other out-of-pocket expenses for Medicare and Medicaid patients taking… Read More »

Novartis bids goodbye to Hudson, hello to new pharma chief Tschudin

In the game of executive musical chairs triggered by Sanofi CEO Olivier Brandicourt’s exit, Novartis lost its pharma chief, Paul Hudson. But it was ready with a replacement: Marie-France Tschudin, who joined the company in January 2017 from Celgene. Tschudin takes the baton from Hudson as Novartis revs up several new launches and builds out… Read More »

Novartis could settle for $1B as part of federal kickback lawsuit: report

Six years after federal prosecutors first targeted Novartis for an alleged kickback scheme involving $ 10,000 dinners and fishing trips for doctors, signs pointed to the Swiss drugmaker finally having its day in court. Now, it looks like that may not happen. Novartis could be approaching a billion-dollar settlement with the U.S. government as part… Read More »